VANI Director/10% owner reports two stock purchases at $1.12 and $1.26
Rhea-AI Filing Summary
Vivani Medical (VANI) insider filed a Form 4 reporting open-market style private purchases. On 10/15/2025, the reporting person, a Director and 10% Owner, acquired 1,473,214 shares at $1.12 per share pursuant to a Share Purchase Agreement dated March 26, 2025, and 264,550 shares at $1.26 per share pursuant to a Share Purchase Agreement dated August 11, 2025.
Following these transactions, beneficial ownership stood at 17,647,112 shares held indirectly and 4,799,200 shares held directly, for a combined 22,446,312 shares with voting and dispositive power over all such shares.
Positive
- None.
Negative
- None.
Insights
Director/10% owner increased stake via private purchases; higher ownership concentration and disclosed voting control.
The reporting person, a **Director and 10% Owner** of **Vivani Medical, Inc. (VANI)**, acquired a total of 1,737,764 common shares on
Following these transactions, the filer reports beneficial ownership of **22,446,312** shares, composed of **4,799,200** direct and **17,647,112** indirect, held across specified entities. The filing states **Gregg Williams** has voting and dispositive power over all these shares. This reflects meaningful ownership concentration, which can influence governance outcomes such as board matters and shareholder votes.
Key items to watch include any subsequent Forms 4 showing additional acquisitions or dispositions, and future filings that may reference these Share Purchase Agreements. The reported dates and amounts provide clear markers: execution on
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 1,473,214 | $1.12 | $1.65M |
| Purchase | Common Stock | 264,550 | $1.26 | $333K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The reporting person purchased 1,473,214 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of March 26, 2025 at a price of $1.12 per share, which was the last reported sale price of the Issuer's common stock on the Nasdaq on March 25, 2025 (the day immediately prior to March 26, 2025). The gross proceeds from this private sale transaction were $1,649,999.68. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote. The reporting person purchased 264,550 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of August 11, 2025 at a price of $1.26 per share, which was the last reported sale price of the Issuer's common stock on the Nasdaq on August 10, 2025 (the day immediately prior to August 11, 2025). The gross proceeds from this private sale transaction were $333,333.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote. The reporting person owns 22,446,312 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 15,521,360 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.
